Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

December 31, 2014

Conditions
Central Obesity
Interventions
DIETARY_SUPPLEMENT

soy supplementation

"Isoflavones will be in the form of capsule (80 mg /capsule). Placebo capsule will be filled with cellulose. These capsules will be identical in size and color. Soy protein will be prepared in the form of powder, containing 25 g of soy protein per package. Placebo powder will contain 25 g whole milk protein. Both powders will be available in vanilla and chocolate flavors, and look and taste similar. They could be mixed with water, milk and other beverages. Subjects will be asked to consume 2 capsules and 1 powder packet daily, preferably at breakfast for 6 months.~Subjects failing to show up at the monthly visit for refilling supplement will be contacted by research staff via email or phone."

Trial Locations (1)

78249

Human Nutrition Lab, UTSA, San Antonio

All Listed Sponsors
lead

The University of Texas at San Antonio

OTHER

NCT02375113 - Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women | Biotech Hunter | Biotech Hunter